8G79
 
 | |
8CMA
 
 | SARS-CoV-2 Delta-RBD complexed with BA.4/5-35 Fab | 分子名称: | 2-acetamido-2-deoxy-beta-D-glucopyranose, BA.4/5-35 heavy chain, BA.4/5-35 light chain, ... | 著者 | Zhou, D, Ren, J, Stuart, D.I. | 登録日 | 2023-02-18 | 公開日 | 2024-02-28 | 最終更新日 | 2024-11-13 | 実験手法 | X-RAY DIFFRACTION (3.29 Å) | 主引用文献 | Emerging variants develop total escape from potent monoclonal antibodies induced by BA.4/5 infection. Nat Commun, 15, 2024
|
|
8GWK
 
 | SARS-CoV-2 RNA E-RTC complex with RMP-nsp9 and GMPPNP | 分子名称: | Helicase, MAGNESIUM ION, Non-structural protein 7, ... | 著者 | Yan, L.M, Huang, Y.C, Ge, J, Liu, Z.Y, Gao, Y, Rao, Z.H, Lou, Z.Y. | 登録日 | 2022-09-17 | 公開日 | 2024-02-28 | 最終更新日 | 2025-07-02 | 実験手法 | ELECTRON MICROSCOPY (2.72 Å) | 主引用文献 | A mechanism for SARS-CoV-2 RNA capping and its inhibition by nucleotide analog inhibitors. Cell, 185, 2022
|
|
8GWM
 
 | SARS-CoV-2 E-RTC bound with MMP-nsp9 and GMPPNP | 分子名称: | 2'-deoxy-2'-fluoro-2'-methyluridine 5'-(trihydrogen diphosphate), Helicase, Non-structural protein 7, ... | 著者 | Yan, L.M, Rao, Z.H, Lou, Z.Y. | 登録日 | 2022-09-17 | 公開日 | 2024-02-28 | 最終更新日 | 2025-06-25 | 実験手法 | ELECTRON MICROSCOPY (2.64 Å) | 主引用文献 | A mechanism for SARS-CoV-2 RNA capping and its inhibition by nucleotide analog inhibitors. Cell, 185, 2022
|
|
8WGV
 
 | BA.2(S375) Spike (S6P)/hACE2 complex | 分子名称: | 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, Angiotensin-converting enzyme 2, ... | 著者 | Wei, X, Zhang, Z. | 登録日 | 2023-09-22 | 公開日 | 2024-02-28 | 最終更新日 | 2024-11-13 | 実験手法 | ELECTRON MICROSCOPY (2.92 Å) | 主引用文献 | The receptor binding domain of SARS-CoV-2 Omicron subvariants targets Siglec-9 to decrease its immunogenicity by preventing macrophage phagocytosis. Nat.Immunol., 25, 2024
|
|
8WGW
 
 | Local refinement of RBD-ACE2 | 分子名称: | 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, Angiotensin-converting enzyme 2, ... | 著者 | Wei, X, Zhang, Z. | 登録日 | 2023-09-22 | 公開日 | 2024-02-28 | 最終更新日 | 2024-11-06 | 実験手法 | ELECTRON MICROSCOPY (2.9 Å) | 主引用文献 | The receptor binding domain of SARS-CoV-2 Omicron subvariants targets Siglec-9 to decrease its immunogenicity by preventing macrophage phagocytosis. Nat.Immunol., 25, 2024
|
|
8IG4
 
 | |
8IG8
 
 | |
8IGA
 
 | |
8QO5
 
 | Conserved Structures and Dynamics in 5-Proximal Regions of Betacoronavirus RNA Genomes | 分子名称: | SARS-CoV-2-SL5 | 著者 | Moura, T.R, Purta, E, Bernat, A, Baulin, E, Mukherjee, S, Bujnicki, J.M. | 登録日 | 2023-09-28 | 公開日 | 2024-03-06 | 最終更新日 | 2025-07-02 | 実験手法 | ELECTRON MICROSCOPY (6.5 Å) | 主引用文献 | Conserved structures and dynamics in 5'-proximal regions of Betacoronavirus RNA genomes. Nucleic Acids Res., 52, 2024
|
|
8XE9
 
 | XBB.1.5 RBD in complex with BD55-1205 | 分子名称: | BD55-1205 heavy chain, BD55-1205 light chain, Spike protein S2' | 著者 | Feng, L.L. | 登録日 | 2023-12-11 | 公開日 | 2024-03-06 | 最終更新日 | 2025-06-18 | 実験手法 | ELECTRON MICROSCOPY (3.3 Å) | 主引用文献 | XBB.1.5 RBD in complex with BD55-1205 To Be Published
|
|
8GDR
 
 | |
8INX
 
 | Crystal Structure of SARS-CoV-2 Main Protease (Mpro) G15S Mutant in Complex with Inhibitor ensitrelvir | 分子名称: | 3C-like proteinase, 6-[(6-chloranyl-2-methyl-indazol-5-yl)amino]-3-[(1-methyl-1,2,4-triazol-3-yl)methyl]-1-[[2,4,5-tris(fluoranyl)phenyl]methyl]-1,3,5-triazine-2,4-dione | 著者 | Lin, M, Liu, X. | 登録日 | 2023-03-10 | 公開日 | 2024-03-13 | 最終更新日 | 2025-04-09 | 実験手法 | X-RAY DIFFRACTION (1.66 Å) | 主引用文献 | Molecular mechanism of ensitrelvir inhibiting SARS-CoV-2 main protease and its variants. Commun Biol, 6, 2023
|
|
8INY
 
 | Crystal Structure of SARS-CoV-2 Main Protease (Mpro) K90R Mutant in Complex with Inhibitor ensitrelvir | 分子名称: | 3C-like proteinase, 6-[(6-chloranyl-2-methyl-indazol-5-yl)amino]-3-[(1-methyl-1,2,4-triazol-3-yl)methyl]-1-[[2,4,5-tris(fluoranyl)phenyl]methyl]-1,3,5-triazine-2,4-dione | 著者 | Lin, M, Liu, X. | 登録日 | 2023-03-10 | 公開日 | 2024-03-13 | 最終更新日 | 2025-04-09 | 実験手法 | X-RAY DIFFRACTION (1.59 Å) | 主引用文献 | Molecular mechanism of ensitrelvir inhibiting SARS-CoV-2 main protease and its variants. Commun Biol, 6, 2023
|
|
8R1C
 
 | SD1-2 Fab in complex with SARS-CoV-2 BA.2.12.1 Spike Glycoprotein | 分子名称: | 2-acetamido-2-deoxy-beta-D-glucopyranose, SD1-2 fab heavy chain, SD1-2 fab light chain, ... | 著者 | Duyvesteyn, H.M.E, Ren, J, Stuart, D.I. | 登録日 | 2023-11-01 | 公開日 | 2024-03-13 | 最終更新日 | 2024-11-06 | 実験手法 | ELECTRON MICROSCOPY (2.2 Å) | 主引用文献 | The SARS-CoV-2 neutralizing antibody response to SD1 and its evasion by BA.2.86. Nat Commun, 15, 2024
|
|
8SDF
 
 | |
8SDG
 
 | |
8SIQ
 
 | |
8SIR
 
 | |
8SIS
 
 | |
8SIT
 
 | |
8S8X
 
 | SARS-CoV-2 nsp10-16 methyltransferase in complex with Toyocamycin and m7GpppA-RNA (Cap0-RNA) | 分子名称: | 2'-O-methyltransferase nsp16, 2-(N-MORPHOLINO)-ETHANESULFONIC ACID, 4-amino-7-(beta-D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidine-5-carbonitrile, ... | 著者 | Kremling, V, Sprenger, J, Oberthuer, D, Scheer, T.E.S. | 登録日 | 2024-03-07 | 公開日 | 2024-03-20 | 最終更新日 | 2024-11-13 | 実験手法 | X-RAY DIFFRACTION (1.99 Å) | 主引用文献 | SARS-CoV-2 methyltransferase nsp10-16 in complex with natural and drug-like purine analogs for guiding structure-based drug discovery Elife, 2024
|
|
8TH5
 
 | |
8VEC
 
 | Deep Mutational Scanning of SARS-CoV-2 PLpro | 分子名称: | Papain-like protease nsp3, ZINC ION | 著者 | Wu, X, Nguyen, J.V, Call, M.E, Call, M.J. | 登録日 | 2023-12-18 | 公開日 | 2024-03-20 | 最終更新日 | 2024-08-07 | 実験手法 | X-RAY DIFFRACTION (2 Å) | 主引用文献 | Mutational profiling of SARS-CoV-2 papain-like protease reveals requirements for function, structure, and drug escape. Nat Commun, 15, 2024
|
|
9EMJ
 
 | SARS-CoV-2 methyltransferase nsp10-16 in complex with Toyocamycin and m7GpppA (Cap0-analog) | 分子名称: | 1,2-ETHANEDIOL, 2'-O-methyltransferase nsp16, 4-amino-7-(beta-D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidine-5-carbonitrile, ... | 著者 | Kremling, V, Sprenger, J, Oberthuer, D, Kiene, A. | 登録日 | 2024-03-08 | 公開日 | 2024-03-20 | 実験手法 | X-RAY DIFFRACTION (1.79 Å) | 主引用文献 | SARS-CoV-2 methyltransferase nsp10-16 in complex with natural and drug-like purine analogs for guiding structure-based drug development To Be Published
|
|